[en] The ability of cyclodextrins (CDs) to increase the solubility of cyproterone acetate (CPA) was previously shown by phase-solubility and NMR studies [1]. In the present work, the influence of various CDs on the stability of CPA was studied in pH 6 and pH 8 aqueous solutions at 25degreesC. Different CDs were tested: hydroxypropyl-beta-cyclodextrin (HPbetaCD), randomly methylated beta-cyclodextrin (RAMEB), hydroxypropyl-gamma-cyclodextrin (HPgammaCD) and gamma-cyclodextrin (gammaCD). At pH 6, the presence of these CDs reduces the degradation of CPA. Nevertheless, at pH 8, the gamma-CD derivatives are ineffective against the degradation of CPA, whereas the beta-CD derivatives (HPbetaCD and RAMEB) allow decreasing CPA hydrolysis. Molecular modeling was performed to theoretically calculate some of the most energetically favorable conformations for gamma-CD and RAMEB complexes with CPA. The position of the ester group in the CD caivity seems to be the most important factor influencing the hydrolysis of CPA. Other factors, such as the size of the cavity, the substitution of the CD hydroxyls and the stability constant also have a strong incidence on CPA stability.
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Henry de Hassonville, Sandrine
Dive, Georges ; Université de Liège - ULiège > Centre d'ingénierie des protéines
Evrard, Brigitte ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique
Barillaro, Valery
Bertholet, Pascal
Delattre, Luc ; Université de Liège - ULiège > Département de pharmacie > Département de pharmacie
Piel, Géraldine ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique et magistrale
Language :
English
Title :
Application of molecular modeling to the study of cyproterone acetate stability in the presence of cyclodextrin derivatives
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
HENRY DE HASSONVILLE S., PERLY B., PIEL G., VAN HEES T., BARILLAROV, BERTHOLET P., DELATTRE L., EVRARD B. - Inclusion complexes of cyproterone acetate with cyclodextrins in aqueous solution. - J. Incl. Phenom. Macro. Chem., 44, 289-292, 2002.
CUNLIFFE W.J., SHUSTERS., CASSELS SMITH J. - The effect of topical cyproterone acetate on sebum secretion in patients with acne. - Br. J. Dermatol., 81, 200-201, 1969.
PYE R.J., BURTON J.L., HARRIS J.I. - Effect of 1% cyproterone acetate in cetomacrogol cream BPC (Formula A) on sebum excretion rate in patients with acne. - Br. J. Dermatol., 95, 427-428, 1976.
LYONS F., SHUSTER S. - Indirect evidence that the action of cyproterone acetate is due to a metabolite. - Clinical Endocrinology, 19, 53-55, 1983.
FANTA D. - Hormonal therapy of acne. - In : Hormone Therapy of Acne, Clinical and Experimental Principles, Springer Verlag, Wien-New York, 1978, pp.50-72.
GRUBER D.M., SATOR M.O., JOURA E.A., KOKOSCHKA E.M., HEINZE G., HUBER J.C. - Topical cyproterone acetate treatment in women with acne. - Arch. Dermatol., 134, 459-463, 1998.
LOFTSSON T., MASSON M. - Cyclodextrins in topical drug formulations: theory and practice. - Int. J. Pharm., 225, 15-30, 2001.
MASSON M., LOFTSSON T., MASSON G., STEFANSSON E. - Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing. - J. Control. Rel., 59, 107-118, 1999.
FRÖMMING K.-H., SZEJTLI J. - Stabilizing and catalytic effects in solution. - In : Cyclodextrins in Pharmacy, J.E.D. Davies Ed., Kluwer Academic Publishers, Dordrecht, 1994, pp. 63-68.
DUCHÊNE D., DEBRUÈRES B., VAUTION C. - Improvement of drugs stability by cyclodextrins inclusion complexation. - STP Pharma, 1, 37-43, 1985.
VIANNA R.F., BENTLEY M.V., RIBEIRO G., CARVALHO F.S., NETO A.F., DE OLIVEIRA D.C., COLLETT J.H. - Formation of cyclodextrin inclusion complexes with corticosteroids : their characterization and stability. - Int. J. Pharm., 167, 205-213, 1998.
JARHO P., VANDER VELDE D.G., STELLA V.J. - Cyclodextrin-catalyzed deacetylation of spironolactone is pH and cyclodextrin dependent. - J. Pharm. Sci., 89, 241, 2000.
LOPEZ R.F.V., COLLETT J.H., BENTLEY M.V. - Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone. - Int. J. Pharm., 200, 127-132, 2000.
FRISCH M.J., TRUCKS G.W., SCHLEGEL H.B., SCUSERIA G.E., ROBB M.A., CHEESEMAN J.R., ZAKRZEWSKI V.G., MONTGOMERY J.A.JR., STRATMANN R.E., BURANT J.C., DAPPRICH S., MILLAM J.M., DANIELS A.D., KUDIN K.N., STRAIN M.C., FARKAS O., TOMASI J., BARONE V., COSSI M., CAMMI R., MENNUCCI B., POMELLI C., ADAMO C., CLIFFORD S., OCHTERSKI J., PETERSSON G.A., AYALA P.Y., CUI Q., MOROKUMA K., MALICK D.K., RABUCK A.D., RAGHAVACHARI K., FORESMAN J.B., CIOSLOWSKI J., ORTIZ J.V., BABOUL A.G., STEFANOV B.B., LIU G., LIASHENKO A., PISKORZ P., KOMAROMI I., GOMPERTS R., MARTIN R.L., FOX D.J., KEITHT., AL-LAHAM M., PENG C.Y., NANAYAKKARA A., GONZALEZ C., CHALLACOMBE M., GILL P.M.W., JOHNSON B., CHEN W., WONG M.W., ANDRES J.L., HEAD-GORDON M., REPLOGLE E.S., POPLE J.A. - Gaussian 98. - Revision A.7, Inc., Pittsburgh PA, 1998.
Molden. - Gijs Schaftenaar Centre for Molecular and Biomolecular Informatics University of Nijmegen, Toernooiveld 1, P.O. Box 9010, 6500 GL Nijmegen, 2003.
Mercury. - 1.2.1, The Cambridge Cristallographic Data Centre, Cambridge, UK, 2004.
McQUARRIE D.A. - Statistical thermodynamics - Harper and Row, New York, 1973.
PIEL G., DIVE G., EVRARD B., VAN HEES T., HENRY DE HASSONVILLE S., DELATTRE L. - Molecular modeling study of b- and g-cyclodextrin complexes with miconazole. - Eur. J. Pharm. Sci., 13, 271-279, 2001.
DODZIUK H. - Rigidity versus flexibility. A review of experimental and theoretical studies pertaining to the cyclodextrin nonrigidity. - J. Mol. Struct., 614, 33-45, 2002.
BODOR N., BUCHWALD P. -Theoretical insights into the formation, structure, and energetics of some cyclodextrin complexes. - J. Incl. Phenom. Macro. Chem., 44, 9-14, 2002.
FRÖMMING K.-H., SZEJTLI J. - Cyclodextrins in Pharmacy - J.E.D. Davies Ed., Kluwer Academic Publishers, Dordrecht, 1994, pp.1-224.
UEKAMA K., HIRAYAMA F., IRIE T. - Cyclodextrin drug carrier systems. - Chem. Rev., 98, 2045-2076, 1998.
UEKAMA K., OTAGIRI M. - Cyclodextrins in drug carrier systems. - Critical Reviews in Therapeutic Drug Carrier Systems, 3, 1-40, 1987.
BODOR N., DRUSTRUP J., WU W. - Effect of cyclodextrins on the solubility and the stability of a novel soft corticosteroid, loteprednol etabonate. - Pharmazie, 55, 206-209, 2000.
KLEIN C.T., POLHEIM D., VIERNSTEIN H., WOLSCHANN P. - Predicting the free energies of complexation between cyclodextrins and guest molecules: Linear versus nonlinear models. - Pharm. Res., 17, 358-365, 2000.
BUCHWALD P., BODOR N. - Quantitative structure-metabolism relationships: Steric and nonsteric effects in the enzymatic hydrolysis of noncongener carboxylic esters. - J. Med. Chem., 42, 5160-5168, 1999.
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
